The University of Arizona
Home Clinical Research Unit Current Studies
Clinical Studies Print E-mail

 

 

The University of Arizona Arthritis Center is currently looking for volunteers to participate in the following clinical trials:

 

GOUT STUDY

You may qualify to participate if you:

  • Female, 55 years or older
  • Male, 50 years or older
  • Have gout and a history of cardiac disease like stroke or heart attack or blood circulation problems

 

This is a 5-year study to evaluate the safety of Febuxostat and Allopurinol. Study-related medical care and services are provided at no cost to study participants. Compensation for time and travel will be provided.

 

If you are interested in more information or to see if you qualify, please contact Jessica at 520-626-8219 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 


RHEUMATOID ARTHRITIS CLINICAL RESEARCH STUDY

You may be able to participate in this study, if you:

  • are 18 years of age or older
  • have had adult onset rheumatoid arthritis
  • have had at least one joint erosion in your hand, wrist or foot and your lab test (anti-CCP) is positive for rheumatoid arthritis OR you have at least three joint erosions in your hand, wrist or foot joints
  • are currently receiving treatment with methotrexate

Study participation will last approximately 13 months. Study related medical care and services are provided at no cost to study participants.

 

If you are interested in more information or to see if you qualify, please contact Jessica at 520-626-8219 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

 

RHEUMATOID ARTHRITIS CLINICAL RESEARCH STUDY

 You may be able to participate in this study, if you:

  • are 18 years of age or older
  • have had adult onset rheumatoid arthritis (RA)
  • have moderately to severely active RA
  • have had an insufficient response to conventional DMARDs (such as Methotrexate) and have not previously been treated with a biologic DMARD (such as Enbrel, Humira, Remicade)

This study will investigate the effectiveness and safety of the study drug when used in combination with your current treatment for RA. Study participation will last approximately 7 months. Study related medical care and procedures are provided at no cost to study participants.

 

If you are interested in more information or to see if you qualify, please contact Jessica at 520-626-8219 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

 

 

VASCULITIS CLINICAL RESEARCH STUDY

You may be able to participate in this study, if you:
  • are 18 years of age or older
  • have a diagnosis of Wegener’s granulomatosis (WG) or a diagnosis of microscopic polyangiitis (MPA)
  • have had an episode of moderately to severely active WG or MPA requiring treatment within the last 6 months

This study will evaluate the effectiveness and safety of belimumab in the maintenance of remission following a standard induction regimen in patients with WG or MPA. Study participation will last approximately 2 years or longer with monthly study visit. Study related medical care and services are provided at no cost to study participants.

 

If you are interested in more information or to see if you qualify, please contact Jessica at 520-626-8219 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

 

For More Info Please Contact Us

or Call (520) 626-8219